Sort by
Refine Your Search
-
The Neuropharmacology research group at the Department of Pharmaceutical Sciences seeks applications for an open PhD position. The Neuropharmacology group, led by Prof. Linda Simmler, investigates
-
), hosted by the Gabelica group (Bioanalytical Mass Spectrometry, School of Pharmaceutical Sciences). The global project, conducted by 13 PhD candidates throughout Europe, aims to bring a new fundamental
-
at the Department of Pharmaceutical Sciences seeks applications for an open PhD position. The Neuropharmacology group, led by Prof. Linda Simmler, investigates the mode of action of psychoactive substances pre
-
interfaces with analytical chemistry and computational modeling. Your profile You have, or expect to obtain, an MSc or equivalent in toxicology, chemistry, biochemistry, pharmaceutical sciences, food science
-
Institute (FMI), Biozentrum and University of Basel) as well as major biotechnology and pharmaceutical companies (e.g., Novartis, Roche, Bayer, and Lonza). The ETH Zurich is a global leader in science and
-
techniques International research environment Participation in PhD program Pharmaceutical Sciences Integration in Swiss Centre of Applied Human Toxicology network Application / Contact Applications should
-
activities, respect in the workplace, and open-mindedness to new ideas An excellent bachelor’s and master’s degree (or equivalent) in pharmacology, medicine, pharmacy, pharmaceutical sciences, biochemistry
-
master theses. Your profile Requirements for this PhD position are: A strong background in medical sciences Good knowledge of in vitro and in vivo pharmacology Fluency in scientific English writing and
-
100%, Basel, fixed-term The Computational Evolution Group, led by Prof. Dr. Tanja Stadler, in the Department of Biosystems Science and Engineering (D-BSSE) at ETH Zurich works at the interface